The success of the Drug, Cosmetic and Toiletry Wholesaling industry is driven by the nondiscretionary nature of its primary product: pharmaceuticals. The majority of industry revenue is sourced from the distribution of prescription and non-prescription drugs to a variety of retailers and healthcare providers. Consolidation within the industry has increased over the past five years, as already powerful wholesalers have expanded their market share. In the coming years, several trends are expected to bode well for the industry. The industry will benefit from a rise in the number of people with access to healthcare and insurance, and rising per capita disposable income will enable consumers to better afford health products, discretionary cosmetics and toiletries.
Drug, cosmetic and toiletry wholesalers primarily distribute pharmaceutical products intended for internal and external consumption, such as tablets, capsules, vials, ointments and powders. The industry includes a range of biological and medical products, and botanical drugs and herbs. The industry does not include businesses that primarily distribute surgical, dental or hospital equipment.
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.
